Alvotech News

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Alvotech (ALVO) and Pacific Biosciences (PACB)

TipRanksApr 17 03:30 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)

TipRanksApr 5 03:50 ET

Alvotech Analyst Ratings

BenzingaMar 22 06:40 ET

Alvotech Analyst Ratings

BenzingaJan 29 05:19 ET

Alvotech Upgraded at Citi Citing FDA Nod for Biosimilars

Seeking AlphaOct 20, 2023 10:25 ET

Citigroup Upgrades Alvotech to Neutral, Raises Price Target to $10

BenzingaOct 20, 2023 06:15 ET

Alvotech Analyst Ratings

BenzingaOct 20, 2023 06:14 ET

Citi Upgrades Alvotech (ALVO) to a Hold

TipRanksOct 20, 2023 04:26 ET

Barclays Initiates Coverage On Alvotech With Equal-Weight Rating, Announces Price Target of $10

BenzingaSep 21, 2023 05:09 ET

Alvotech Analyst Ratings

BenzingaSep 21, 2023 05:08 ET

Deutsche Bank Adjusts Alvotech's Price Target to $12 From $8, Maintains Hold Rating

MT NewswiresMar 7, 2023 10:41 ET

Morgan Stanley Starts Alvotech at Equalweight With $10 Price Target

MT NewswiresSep 7, 2022 06:40 ET

Alvotech Price Target Announced at $10.00/Share by Morgan Stanley

Dow JonesSep 7, 2022 05:10 ET

Alvotech Price Target Cut to $5.00/Share From $12.00 by Citigroup

Dow JonesSep 6, 2022 10:16 ET

Citigroup Double Downgrades Alvotech to Sell From Buy, Adjusts Price Target to $5 From $12

MT NewswiresSep 6, 2022 07:44 ET

Citigroup Starts Alvotech at Buy With $12 Price Target

MT NewswiresJul 26, 2022 06:47 ET

Icelandic biosimilars developer Alvotech initiated with a hold rating by Deutsche Bank

Seeking AlphaJul 1, 2022 12:55 ET

Deutsche Bank Initiates Coverage on Alvotech With Hold Rating, $10 Price Target

MT NewswiresJul 1, 2022 09:52 ET

Alvotech Initiated at Hold by Deutsche Bank

Dow JonesJul 1, 2022 06:11 ET

Alvotech Price Target Announced at $10.00/Share by Deutsche Bank

Dow JonesJul 1, 2022 06:11 ET